Published in Rheumatology (Oxford) on December 01, 2000
Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci U S A (2003) 1.47
The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus. J Med Genet (2007) 1.16
Haematological manifestations of lupus. Lupus Sci Med (2015) 0.89
Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity. Lupus (2013) 0.89
Serum Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis? Nephron Extra (2012) 0.78
Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus. J Clin Immunol (2013) 0.78
Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol (2015) 0.78
Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis. Medicine (Baltimore) (2016) 0.78
Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus (2010) 0.77
Basophil count, a marker for disease activity in systemic lupus erythematosus. Clin Rheumatol (2014) 0.77
The predictive value of ANA and anti-dsDNA antibodies for flares in SLE. Rheumatology (Oxford) (2001) 0.75
Estrogen receptor alpha promotes lupus in (NZB×NZW)F1 mice in a B cell intrinsic manner. Clin Immunol (2016) 0.75
The universe of ANA testing: a case for point-of-care ANA testing. Auto Immun Highlights (2017) 0.75
Subacute steroid-induced paraparesis: surgical treatment of a devastating "invisible" side effect. Eur Spine J (2012) 0.75
[Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study]. Pan Afr Med J (2015) 0.75
Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study. Clin Rheumatol (2017) 0.75
Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol (1988) 4.06
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity (1996) 2.96
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (1985) 2.51
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS (1999) 2.47
The IgG Fc receptor family. Ann Hematol (1998) 2.28
CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol (2001) 2.13
Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia (2005) 2.08
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (1985) 1.83
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med (1986) 1.63
Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis. Arthritis Rheum (1991) 1.56
Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest (1993) 1.53
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol (1998) 1.49
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
A mass in the eye. Lancet (2002) 1.46
Chronic headache resulting from postoperative supraorbital neuralgia. Anesth Analg (1991) 1.45
Biology of GPI anchors and pathogenesis of paroxysmal nocturnal hemoglobinuria. Immunol Today (1994) 1.43
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis (2008) 1.42
Towards a better definition of human leucocyte surface molecules. Immunol Today (1989) 1.42
FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood (1998) 1.40
Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases. Clin Nephrol (1993) 1.40
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J Exp Med (1985) 1.37
The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol (1994) 1.36
Association of multiple sclerosis with ILT6 deficiency. Genes Immun (2005) 1.34
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J (1999) 1.33
Characterization of functional surface structures on human natural killer cells. Adv Immunol (1988) 1.30
Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis (1998) 1.27
Specific release of proteoglycans from human natural killer cells during target lysis. Nature (1985) 1.26
Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice. Blood (1999) 1.25
Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol Chem (1999) 1.25
Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J Immunol (2001) 1.24
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol (1997) 1.24
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J Immunol (1985) 1.22
CD16- CD56+ natural killer cells after bone marrow transplantation. Blood (1992) 1.21
Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab (1996) 1.19
The glycosylphosphatidylinositol-linked Fc gamma receptor III represents the dominant receptor structure for immune complex activation of neutrophils. Eur J Immunol (1992) 1.18
Changes of natural killer cells during acute psychological stress. J Clin Immunol (1993) 1.18
Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants. J Biol Chem (1992) 1.17
Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol (1993) 1.17
A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J Immunol (2000) 1.17
Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med (2000) 1.16
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun (2012) 1.16
Simultaneous detection of TDT-mediated dUTP-biotin nick end-labeling (TUNEL)-positive cells and multiple immunohistochemical markers in single tissue sections. Biotechniques (1995) 1.16
Role of nerve growth factor in the adult dorsal root ganglia neuron and its response to injury. J Comp Neurol (1984) 1.14
Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol (2001) 1.14
Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol (1998) 1.13
Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes. Eur J Immunol (1986) 1.12
Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol (2001) 1.12
Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis (2009) 1.11
Characteristics and uses of natural killer cells. Immunol Today (1988) 1.09
Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun (2007) 1.08
The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding. J Immunol (1996) 1.08
Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci (1990) 1.07
Fc gamma RIII-mediated production of TNF-alpha induces immune complex alveolitis independently of CXC chemokine generation. J Immunol (2001) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Enhancement of natural killer function through activation of the T11 E rosette receptor. J Clin Invest (1987) 1.05
The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol (2013) 1.05
Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur J Immunol (2000) 1.04
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity. J Exp Med (1986) 1.04
Systemic pathology of chimpanzees. J Med Primatol (1975) 1.04
Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun (2007) 1.04
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis (2010) 1.02
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet (1981) 1.02
Patients' attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol (2006) 1.02
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol (1985) 1.02
Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood (1994) 1.02
Positional support for premature infants. Am J Occup Ther (1986) 1.02
Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol (1991) 1.02
Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. Genes Immun (2009) 1.01
Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J Immunol (1999) 1.01
Mycobacterium genavense. Autopsy findings in three patients. Am J Clin Pathol (1994) 1.01
Experimental diabetic autonomic neuropathy. Am J Pathol (1981) 1.01
Lack of specific receptors for C-reactive protein on white blood cells. Eur J Immunol (2001) 1.00
IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol Int (1998) 1.00
The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis (2008) 0.99
CD antigens 1989. Blood (1989) 0.99
In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. Blood (1987) 0.98
Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS (1999) 0.98
Association of immunoglobulin-like transcript 6 deficiency with Sjögren's syndrome. Arthritis Rheum (2009) 0.97
The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction. Immunology (1997) 0.97
The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain. J Biol Chem (1996) 0.97
Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol (1996) 0.96
Fast and slow axoplasmic flow in sciatic nerve of diabetic rats. Diabetes (1975) 0.96
Double-positive T cell receptor(high) thymocytes are resistant to peptide/major histocompatibility complex ligand-induced negative selection. Eur J Immunol (1997) 0.96
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Ann Rheum Dis (2012) 0.95
Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf (2000) 0.95
Retrograde axonal transport of intravenously administered 125I-nerve growth factor in rats with streptozotocin-induced diabetes. Diabetes (1983) 0.95